CHINA PHARMA HOLDINGS, INC. Restricted Cash, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Restricted Cash, Current of $331.04 thousand as of 2020-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2021-05-14
- 2020-03-31: Restricted Cash, Current $331.04K.
- 2019-12-31: Restricted Cash, Current $109.91K.
| Period end | Restricted Cash, Current |
|---|---|
| 2020-03-31 | $331.04K 10-Q · filed 2021-05-14 |
| 2019-12-31 | $109.91K 10-K · filed 2021-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |